Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) Gross Profit: 2019-2025

Historic Gross Profit for Legend Biotech (LEGN) over the last 7 years, with Sep 2025 value amounting to $272.3 million.

  • Legend Biotech's Gross Profit rose 69.99% to $272.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $722.6 million, marking a year-over-year increase of 63.94%. This contributed to the annual value of $410.9 million for FY2024, which is 191.55% up from last year.
  • Legend Biotech's Gross Profit amounted to $272.3 million in Q3 2025, which was up 6.77% from $255.1 million recorded in Q2 2025.
  • Over the past 5 years, Legend Biotech's Gross Profit peaked at $272.3 million during Q3 2025, and registered a low of $79,464 during Q4 2023.
  • Moreover, its 3-year median value for Gross Profit was $96.0 million (2023), whereas its average is $124.5 million.
  • The largest annual percentage gain for Legend Biotech's Gross Profit in the last 5 years was 512.56% (2023), contrasted with its biggest fall of 99.71% (2023).
  • Over the past 5 years, Legend Biotech's Gross Profit (Quarterly) stood at $39.0 million in 2021, then declined by 29.14% to $27.6 million in 2022, then crashed by 99.71% to $79,464 in 2023, then surged by 134.73% to $186,522 in 2024, then spiked by 69.99% to $272.3 million in 2025.
  • Its last three reported values are $272.3 million in Q3 2025, $255.1 million for Q2 2025, and $195.1 million during Q1 2025.